August 5, 2024
LONDON/NEW YORK (Reuters) – As Eli Lilly’s weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk’s Wegovy, some doctors say their guiding principle for […]
August 5, 2024
FDA recognizes that there is much that is not known scientifically about kratom. Although there are published animal studies with kratom extracts containing mitragynine or 7-OH-mitragynine, […]
August 5, 2024
VIENNA — Nipocalimab, iscalimab, and tibulizumab, but not lusvertikimab, appear to be promising new agents for Sjögren disease that warrant further investigation, suggest the results of […]
August 5, 2024
TOPLINE: Chronic exposure to air pollutants such as fine particulate matter ≤ 2.5 μm in diameter (PM2.5), particulate matter ≤ 10 μm in diameter (PM10), nitrogen […]
August 5, 2024
TOPLINE: In a network meta-analysis (NMA) from a living systematic review, lebrikizumab and dupilumab showed similar efficacy in patients with atopic dermatitis (AD). METHODOLOGY: Researchers evaluated […]
August 5, 2024
TOPLINE: A study found significant associations between melasma and several comorbidities, including hypertension and hormonal contraception use, which were the most common. METHODOLOGY: Melasma predominantly affects […]
August 5, 2024
TOPLINE: A study found significant associations between melasma and several comorbidities, including hypertension and hormonal contraception use, which were the most common. METHODOLOGY: Melasma predominantly affects […]
August 3, 2024
Share on PinterestThe FDA has approved a new colorectal cancer blood test by Guardant Health called Shield for Medicare coverage. Photo by Business Wire for Guardant […]
August 3, 2024
Share on PinterestA new study found that Gen Xers and Millennials have a higher risk of 17 types of cancer compared to previous generations. pocketlight/Getty Images […]